Form 4: Intuitive Surgical EVP Sells Shares Under 10b5-1 Plan

Intuitive Surgical's EVP & Chief Digital Officer, Brian Miller, exercised stock options and sold an equivalent number of common shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Brian Miller, Executive Vice President and Chief Digital Officer of Intuitive Surgical Inc. (ISRG), engaged in multiple transactions on November 10, 2025.
• Miller exercised options to acquire 1,298 shares of common stock at an exercise price of $229.39 per share.
• Concurrently, he sold 1,298 shares of common stock at a price of $575 per share.
• He also exercised options to acquire an additional 2,202 shares of common stock at an exercise price of $208.9 per share.
• Simultaneously, he sold 2,202 shares of common stock at a price of $575 per share.
• All reported transactions were conducted in accordance with a Rule 10b5-1 trading plan, which is set to expire on December 10, 2025.
• Following these transactions, Miller directly beneficially owns 5,758 shares of Intuitive Surgical common stock.
• His remaining derivative holdings include 2,115 non-qualified stock options with an exercise price of $208.9, expiring on August 28, 2029, and 6,602 non-qualified stock options with an exercise price of $229.39, expiring on February 27, 2030.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions (exercise and sale of stock options) under a pre-arranged 10b5-1 plan, indicating a planned monetization of vested equity by an executive. The sale price significantly exceeds the exercise price, reflecting a profitable transaction for the executive, which is generally neutral to slightly positive as it's a normal part of compensation.

Positives

• The executive successfully monetized vested stock options, realizing a significant profit as the sale price of $575 per share was substantially higher than the exercise prices of $229.39 and $208.9 per share.
• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planning and adherence to insider trading regulations, which promotes transparency and reduces concerns about opportunistic selling.

Negatives

• The sale of shares by an executive, even if pre-planned, could be perceived by some investors as a lack of confidence, although this is a common practice for executive compensation and liquidity management.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transactions represent a minor, pre-planned change in insider ownership and are unlikely to have a material impact on the company's stock price or valuation. The executive's continued significant holdings demonstrate ongoing alignment with shareholder interests.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The Rule 10b5-1 trading plan under which these transactions occurred is set to expire on December 10, 2025.

Key Dates

Recommendation

This Form 4 details routine, pre-planned insider transactions by an executive exercising stock options and selling an equivalent number of shares. Such transactions are common for executive compensation and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation based solely on this filing. The company's broader financial health and strategic initiatives would be more relevant factors for an investment decision.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Options, Executive Compensation, Rule 10b5-1, Share Sale